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Abstract. Cadherins are calcium-dependent cell adhe- 
sion molecules that play fundamental roles in embry- 
onic development, tissue morphogenesis, and cancer. A 
prerequisite for their function is association with the ac- 
tin cytoskeleton via the catenins. Tyrosine phosphory- 
lation of 13-catenin, which correlates with a reduction in 
cadherin-dependent cell adhesion, may provide cells 
with a mechanism to regulate cadherin activity. Here 
we report that ~3-catenin immune precipitates from 
PC12 cells contain tyrosine phosphatase activity which 
dephosphorylates 13-catenin in vitro. In addition, we 
show that a member of the leukocyte antigen-related 
protein (LAR)-related transmembrane tyrosine phos- 
phatase family (LAR-PTP) associates with the cad- 
herin-catenin complex. This association requires the 
amino-terminal domain of 13-catenin but does not re- 
quire the armadillo repeats, which mediate association 
with cadherins. The interaction also is detected in PC9 
cells, which lack a-catenin. Thus, the association is not 
mediated by a-catenin or by cadherins. Interestingly, 
LAR-PTPs are phosphorylated on tyrosine in a TrkA- 
dependent manner, and their association with the cad- 
herin--catenin complex is reduced in cells treated with 
NGF. We propose that changes in tyrosine phosphory- 
lation of ~3-catenin mediated by TrkA and LAR-PTPs 
control cadherin adhesive function during processes 
such as neurite outgrowth. 
C 
ADHERINS are  calcium-dependent cell-cell  adhe- 
sion molecules that  are  important regulators of 
morphogenesis  (Takeichi,  1991). Their  function 
requires association with the catenins, which link the highly 
conserved cadherin cytoplasmic domain to the actin-based 
cytoskeleton. 13-Catenin plays a key regulatory role in cad- 
herin  function since  it connects cadherins to ct-catenin, 
which is believed to bind the actin cytoskeleton directly 
(Rimm et al., 1995) or through a-actinin (Knudsen et al., 
1995). f~-Catenin also associates  with the tumor-suppres- 
sor gene product (APC) adenomatous polyposis coli, and, 
together with the related protein, plakoglobin, and Arma- 
dillo (the Drosophila form of 13-catenin), is implicated in 
the  Wnt/Wingless  signaling  pathway, which  determines 
the dorsoventral axis in Xenopus  and segment polarity in 
Drosophila  (for references see  Hinck et al.,  1994; Kirk- 
patrick and Peifer, 1995). 
Activation of several tyrosine kinases induces tyrosine 
phosphorylation of 13-catenin (Matsuyoshi et al., 1992; Beh- 
rens et al., 1993; Hamaguchi et al., 1993; Hoschuetsky et 
al., 1994; Ochiai et al., 1994; Shibamoto et al., 1994). This 
phosphorylation correlates with perturbation of cadherin 
function in  a  number of cell  types,  as measured by de- 
creases  in cell  aggregation (Matsuyoshi et al., 1992; Ha- 
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maguchi et al., 1993), increases in cell migration (Hamagu- 
chi et al., 1993; Shibamoto et al., 1994), and loss of epithelial 
differentiation (Behrens et al., 1993). Inhibitors of tyrosine 
kinases block many of these physiological responses, while 
they  are  enhanced  by  an  inhibitor  of  tyrosine  phos- 
phatases,  sodium orthovanadate (Matsuyoshi et al., 1992; 
Hamaguchi et al., 1993). Furthermore, N-cadherin-depen- 
dent neurite outgrowth of neurons is blocked by vanadate 
(Bixby and Jhabvala, 1992; Kypta, R.M., unpublished ob- 
servations)  and can be blocked or potentiated by tyrosine 
kinase inhibitors,  depending on the cell type (Bixby and 
Jhabvala, 1992; Williams et al., 1994; Kypta, R.M., unpub- 
lished observations). Thus, a dynamic balance of phosphor- 
ylation and dephosphorylation of 13-catenin may regulate 
cadherin-dependent cell interactions. 
There  are  several  ways  in  which  phosphorylation of 
~3-catenin might regulate cell  function.  For example,  ty- 
rosine phosphorylation of 13-catenin may result in changes 
in the associations of components in the cadherin-catenin 
complex.  Consistent with this possibility,  transformation 
of epithelial cells by ras, which increases tyrosine phosphor- 
ylation of 13-catenin, results  in  dissociation  of 13-catenin 
and  cadherin,  concomitant with  stronger  association  of 
p120 Cas  with  cadherin  (Kinch  et  al.,  1995). Tyrosine 
phosphorylation of 13-catenin may also regulate its ability 
to signal; in Drosophila, Wingless negatively regulates Ar- 
madillo phosphorylation on serine  and tyrosine residues 
(Peifer et al.,  1994). An understanding of the pathways 
that lead to dephosphorylation of 13-catenin may help us 
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phosphorylation. 
In this paper, we show that [3-catenin is subject to rapid 
dephosphorylation, both in vitro and in vivo. We have in- 
vestigated the mechanism for this dephosphorylation and 
found  that  the  cadherin-catenin  complex  is  associated 
with a member of the leukocyte common antigen-related 
protein  (LAR)  1  subfamily  of  transmembrane  tyrosine 
phosphatases (LAR-PTP). There are  three known LAR- 
PTPs  (LAR  [Streuli  et  al.,  1988], PTP8  [Krueger et  al., 
1990; Mizuno et al., 1993], and PTP-P1  (Pan et al.,  1993), 
also known as PTP NE-3, RPTPg, CRYPot, and LAR-2 
[Walton et al., 1993; Yan et al., 1993; Stoker, 1994; Zhang 
et al., 1994]), all of which have extracellular domains con- 
sisting of immunoglobulin-like domains  and  fibronectin 
type III domains, and at least two of which are expressed 
in PC12 cells. Our data suggest potential mechanisms by 
which cadherin-dependent processes  might be  regulated 
by tyrosine dephosphorylation. 
Materials and Methods 
Cell Culture, Labeling, and Transfection 
The PC12 cell line expressing human trk, PC12 6-24 (from Dr. D. Kaplan, 
MeGill University, Montreal,  Quebec)  was grown according to  Hemp- 
stead et al. (1992). Cells were incubated for 16 h  in low-serum medium 
(LSM: 10% normal growth medium in DME) in the presence or absence 
of 30 ng/ml NGF (from Dr. W. Mobley) before lysis and immune precipi- 
tation, For Fig. 2 a, cells were incubated for 4 h  in methionine and cys- 
teine-fi'ee growth medium containing dialyzed serum and 1 mCi/ml Trans- 
label (ICN Biomedicals, Inc., Costa Mesa, CA). PC12 cells were grown on 
collagen (Vitrogen,  Celtrix  Labs, Palo  Alto,  CA),  in  DME  containing 
t0% horse serum and 5% FCS. PC9 cells (kindly provided by M. Takei- 
chi, Kyoto University, Japan) were grown in a  1:1 mixture of DME and 
Ham's F12 supplemented with 10% FCS. 
COS cells were grown in DME containing 10% FCS. Transient trans- 
fections were done in Optimem 1 using Lipofectamine (GIBCO  BRL, 
Gaithersburg,  MD)  according  to  manufacturers protocols.  Cells  were 
transfected in serum-free medium for 6 h and then grown for 16 h in Opti- 
mere 1 with 10% FCS, followed by 8-10 h in DME with 10% FCS and fi- 
nally t8-24 h in DME with 1% FCS. 
Antibodies 
Antibodies recognizing 13-catenin were generated as follows: Xenopus 
l$-catenin eDNA (McCrea et al., 1991) (from Drs. P. McCrea, MD Ander- 
son Cancer Center, Houston, TX, and B. Gumbiner, Sloan-Kettering Can- 
eer Center, New York) was expressed in Sf9 cells using a baculovirus ex- 
pression system (CIontech, Palo Alto, CA) and purified on NTA-agarose 
(Oiage~ Inc., Chatsworth, CA) by means of six carboxyl-terminal histi- 
dine residues generated by PCR. (PCR-generated fragments were either 
sequenced or replaced by sequences from the original [3-catenin clone.) 
Purified  protein  was  injected  into  rabbits  for  production  of  antisera 
(CALTAG, San Francisco, CA). Anti-a-catenin antibodies were gener- 
ated in rabbits using as immunogen the peptide CSQKKHISPVQALSE- 
FKAMDSF, corresponding to the carboxyl-terminat residues of chicken 
aN-catenin, coupled to maleimide-activated keyhole limpet hemocyanin 
(KLH; Pierce, Rockford, IL). Anti-4i-end antibodies were raised in rab- 
bits ~sing as immunogen the peptide CYQAALEYLGSFDHYAT cou- 
to KLH. The control antibody used was raised in rabbits against the 
¢x~atra] peptide (CDQYKFCYEVALEYLNSG) coupled to KLH. Mono- 
clonal antibodies to  human LAR  and receptor  protein  tyrosine  phos- 
phatase RPTP5 were  kindly provided by Dr.  M.  Streuli  (Dana-Farber 
L Abbrevi~ions used in this paper: LAR, leukocyte antigen-related protein; 
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Cancer Institute, Boston, MA). Antibodies used for Western blotting are 
commercially available (see below). 
DNA Plasmid Constructs 
The 13-catenin constructs were generated as follows: The coding region of 
Xenopus 13-catenin eDNA (McCrea et al., 1991) was amplified by PCR to 
include a sequence encoding a  myc-epitope tag (EQKLISEEDL)  at the 
carboxyl-terminus. The PCR-generated construct was ligated into pCRII 
and the ends were sequenced. Amplified DNA that was not sequenced 
was replaced by subcloning of unamplified fragments from the original 
[3-catenin clone. An Nsil fragment encoding the myc-tagged 13-catenin 
(13myc) was subcloned into the PstI site of the COS cell expression vector 
pMT23 (from Dr.  Gordon Wong, Genetics Institute, Cambridge, MA). 
13ANmyc was generated by deleting the sequences upstream of the unique 
Xhol  site, thereby  encoding a  protein  beginning at  methionine 174  of 
13myc. 13ACmyc comprises residues 1-698 of 13-catenin with a myc tag. It 
was generated by deletion mutagenesis using the Transformer Mutagene- 
sis Kit (Clontech, Palo Alto, CA) and a mutagenic oligonucleotide that re- 
moved the  sequences encoding residues 699-781.  13ANACmyc encodes 
residues 173-698 of 13-catenin with a myc tag and was generated by delet- 
ing the sequences upstream of the unique XhoI site in 13ACmyc. 13ARmyc 
was generated by deleting the sequences between the unique Xhol and 
XbaI sites in 13myc. It encodes a protein containing residues 1-151 fused 
to residues 648-781 followed by the myc-epitope tag. Rat TrkA eDNA 
(kindly provided by Dr. D. Clary, SUGEN, Redwood City, CA) was also 
subcloned into pMT23 in sense and antisense orientations. Human LAR 
(Streuli et al., 1988)  and RPTP8 (Pulido et al., 1995a) eDNA expression 
vectors were kindly provided by Dr. M. Streuli. 
Cell Lysis and Immune Precipitation 
All reagents were from Sigma Chemical Co. (St. Louis, MO) unless speci- 
fied. Sodium orthovanadate was prepared as described (Brown and Gor- 
don, 1984) and added to 0.1 mM at 37°C. Before lysis, cells (~2 ×  10 -6 per 
10-cm plate) were washed once in PBS, except for experiments involving 
phosphatase assays, where they were washed in Tris-buffered saline (TBS: 
50 mM Tris-Cl, pH 7.5,  150 mM NaC1) with 0.1 mM DTI  r. Cell lysis was 
for 10 min on ice in 1 ml lysis buffer (LB: 20 mM Tris-Cl, pH 8.0. 150 mM 
NaC1, 50 mM NaF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM EDTA, 
1% NP-40, 1 mM sodium molybdate, and 0.1 mM sodium orthovanadate). 
For experiments where the association between LAR-PTPs and the cad- 
herin--catenin complex was being studied,  LB  contained  10  mM DTT 
and 0.1  mg/ml 4-(2-aminoethyl)-benzene-sulfonyl fluoride hydrochlorine 
(AEBSF)  (ICN Biomedicals, Inc.). For experiments in PC12 6-24 cells 
where tyrosine phosphorylation was being studied, LB did not contain 
DTT. Octylglucoside lysis buffer was LB containing 40 mM octylglucoside 
instead of NP-40. For experiments where LAR and RPTP8 tyrosine phos- 
phorylation were studied in COS cells, cell lysis was in a modified RIPA 
buffer (LB containing 1%  Triton X-100, 0.5%  deoxycholate, and 0.1% 
SDS instead of NP-40, plus 5 mM sodium pyrophosphate, 1 mM molyb- 
date, and 0.5 mM vanadate). Cell lysates were scraped on ice and clarified 
at 15,000 g for 12 min at 4°C. For Fig. 2 a, cell extracts were precleared us- 
ing protein A-Sepharose (Pharmacia LKB Biotechnology, Inc., Uppsala, 
Sweden). Depletion experiments were performed by incubating PCI2 cell 
extracts for 2 h with antibodies bound to protein A-Sepharose (protein 
A-Sepharose was incubated for 16 h in the presence of 50 p.l of antiserum 
and washed three times with lysis buffer before use) and then for an addi- 
tional 30 min with unbound beads. The control antibody used for these ex- 
periments was raised to an unrelated peptide. Immune precipitates were 
prepared at 4°C by incubating with 8 ~1 antiserum for i  h, followed by in- 
cubation for 30 min at 4°C on a  rotator with protein A-Sepharose. Im- 
mune complexes were washed four times in lysis buffer and once in TBS 
containing 0.1 mM vanadate. 
Phosphatase Assays 
Cells were washed and lysed using LB without molybdate and vanadate, 
but with 10 mM DTI'. Immune complexes were washed four times in LB 
and once in phosphatase buffer (20 mM Tris-Cl, pH 6.8,  10 mM DTT). 
Phosphatase assays were conducted in 50 p.l phosphatase buffer with or 
without 0.1 mM vanadate and 0.1 mM phosphopeptide DADEpYLIPQQG 
(Promega Corp., Madison, Wl). The serine-phosphorylated peptide used 
in some control experiments was GENPIYKpSAVITVVNPKYEGK,  a 
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(a gift from D.Y.  Wu, University of California, San Francisco,  CA). For 
peptide dephosphorylation, immune complexes were prepared using 200 
~,g extract, and phosphate released was measured using malachite green 
according to manufacturers instructions (Promega Corp.).  Reactions were 
approximately linear over the time assayed.  Control immune precipitates 
were done using preimmune serum, rabbit IgG, or antisera raised to unre- 
lated peptides, and all gave similar results. 
Western Blotting 
Washed immune complexes were heated to 100°C for 5 rain in reducing 
SDS sample buffer, separated on 6% polyacrylamide gels, and transferred 
to nitrocellulose (BA83; Schleicher & Schuell,  Inc., Keene, NH) using a 
semi-dry  apparatus (Millipore Corp.,  Bedford, MA). Membranes were 
rinsed in 10 mM Tris-Cl,  pH 7.5, 100 mM NaCl, 0.1% Tween-20 (TBS-T) 
and incubated in blocking buffer (TBS-T with 3% BSA, 1% ovalbumin) 
for 1 h. Primary antibodies were diluted in blocking buffer and incubated 
with membranes for 2-16 h. Anti~5-end antibodies were used at 1:100, a 
rat monoclonat antibody to a-catenin (et-18 from Drs. A. Nagafuchi and 
S. Tsukita [Nagafuchi  and Tsukita, 1994]) at 1:20, 13-catenin monoclonal 
antibody (Transduction Laboratories, Lexington, KY) at 1:1,000, pan-cad- 
herin polyclonal and monoclonal antibodies (Sigma Chemical Co.) at 1:500, 
anti-myc epitope tag monoclonal antibody (9E10;  Santa Cruz  Biotech. 
Inc.,  Santa Cruz, CA)  at  1:1,000, and HRP-conjugated  antiphosphoty- 
rosine  antibody RC20H  (Transduction Laboratories) at  t:2,000.  Mem- 
branes were washed in TBS-T and probed with either HRP-conjugated 
(GIBCO BRL) or alkaline phosphatase-coniugated (Promega Corp.) sec- 
ondary antibodies according to manufacturers instructions. Blots were de- 
veloped using chemiluminescence for HRP-conjugated antibodies (ECL; 
Amersham Corp., Arlington Heights, IL), or using 160 ~g/ml 4-nitro blue 
tetrazolium chloride  (NBT)  and  80  p.g/ml 5-bromo-4-chtoro-3-indolyl- 
phosphate (BCIP) in 100 mM NaC1, 5 mM MgC12, 100 mM Tris, pH 9.5, 
for alkaline phosphatase-coniugated antibodies. Where indicated in the 
figure legends, blots were stripped by incubation at 65°C in 62.5 mM Tris- 
CI, pH 6.8, 0.1 M 13-mercaptoethanol,  2% SDS for l0 min, followed  by 
washing overnight with several changes of TBS-T before reprobing. 
Results 
fl-Catenin Immune Precipitates Contain Tyrosine 
Phosphatase  Activity 
In experiments directed towards understanding the regu- 
lation of N-cadherin function in  neurons, we have been 
studying tyrosine phosphorylation of 13-catenin in PC12 6-24 
cells.  Since  these  cells  overexpress human  TrkA,  NGF 
treatment results in enhanced and prolonged phosphoryla- 
tion of intracellular proteins (Hempstead et al.,  1992). To 
our surprise, we observed a similar level of 13-catenin  ty- 
rosine  phosphorylation  in  PC12  6-24  cells  and  normal 
PC12 cells (Kypta, R.M., unpublished observations), sug- 
gesting that a tyrosine phosphatase (PTP) acting preferen- 
tially  on  [3-catenin  may compensate  for the  increase  in 
TrkA activity. 
Figure 1.  Phosphotyrosine phosphatase activity associated with 
13-catenin.  (a)  Anti-phosphotyrosine  (upper panel)  or  anti-13- 
catenin (lower panel) Western blots of 13-catenin immune precipi- 
tates from equal amounts of extracts of PC12 6--24 cells either 
untreated (lane 1), treated with 50 ng/ml NGF for 5 min (lane 2), 
treated with 0.1 mM sodium orthovanadate for 30 rain (lane 3), 
treated with 50 ng/m! NGF for 16 h (lane 4), or treated with NGF 
for 16 h  and sodium orthovanadate for the final 30 rain (lane 5). 
For the result shown in the lower panel,  the blot in the upper 
panel was stripped and reprobed with anti-tB-catenin antibodies. 
The lines on the left of each panel indicate the positions of molec- 
ular mass markers (100.6 kD and 71.6 kD). (b) Anti-phosphoty- 
rosine  (upper panel)  or  anti-13-catenin  (lower panel)  Western 
blots IB-catenin immune precipitates from equal amounts of ex- 
tracts of cells treated with NGF for 16 h  and sodium orthovana- 
date for the final 30 min and lysed in the absence ot vanadate. 
Washed  immune  precipitates  were  incubated  in  phosphatase 
buffer with vanadate (lane 1) or without vanadate (lane 2). For 
the result shown in the lower panel, the blot in the upper panel 
was  stripped  and reprobed with anti-13-catenin antibodies. The 
band below  [3-catenin in the  upper panel was  observed also in 
control immune precipitates. The residual signal in lane 2is simi- 
lar  to  that  seen  for  purified  unphosphorytated  [3-catenin.  (c) 
Phosphatase  activity  in  control  antibody  or  13-catenin immune 
precipitates  as  measured  using  a  phosphotyrosyl  peptide  sub- 
strate. In this experiment, 60 pmol of phosphate corresponded to 
100 U  (an OD of 0.1 at 620 nm after addition of malachite green 
reagent). 
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phatase, we examined the effects on [3-catenin phosphory- 
lation of the tyrosine phosphatase inhibitor, sodium ortho- 
vanadate  (Brown and  Gordon, 1984).  In the  absence of 
vanadate, addition of NGF to PC12 6-24 cells for 10 min 
(Fig. 1 a, lane 2) or 16 h (lane 3) increased tyrosine phos- 
phorylation of [3-catenin.  Interestingly, addition of vana- 
date to PC12 6-24 cells also increased tyrosine phosphory- 
lation of 13-catenin, even in the absence of NGF (lane 4). 
[3-Catenin phosphorylation was dependent on TrkA activity 
since the effects of vanadate were blocked by the TrkA in- 
hibitor Tyrphostin AG879 and by K252a (data not shown). 
The latter is a relatively broad specificity kinase inhibitor 
that nonetheless inhibits purified TrkA in vitro and blocks 
the effects of NGF (but not FGF) on PC12 cells in vivo 
(Berg et al.,  1992;  Nye et al.,  1992;  Tapley et  al.,  1992; 
Ohmichi et al., 1993).  Addition of vanadate to PC12 6-24 
cells that had been treated with NGF for 16 h resulted in 
dramatically elevated phosphorylation of 13-catenin  (lane 
5). Increased tyrosine phosphorylation of 13-catenin  after 
addition of vanadate also was observed using ~-catenin 
immune precipitates and was detected in another cell line 
which  expresses human  TrkA  (PC12  6-15  cells;  Hemp- 
stead et al., 1992) (data not shown). The changes in [3-cate- 
nin tyrosine phosphorylation were not due to changes in 
[3-catenin levels, as shown by reprobing the blot with anti- 
13-catenin antibodies (Fig. 1 a, lower panel). 
The  increased  phosphorylation  of  13-catenin  in  cells 
treated with NGF or vanadate and the inhibition of this 
phosphorylation by inhibitors of TrkA suggest that [3-cate- 
nin phosphorylation is tightly regulated by the activities of 
TrkA and a  tyrosine phosphatase. To test the possibility 
that  [3-catenin is  associated with a  tyrosine phosphatase, 
immune  precipitates  containing  tyrosine-phosphorylated 
13-catenin were prepared from extracts of PC12 6-24 ceils 
that had been treated with NGF and vanadate (which was 
removed before lysis). Washed immune precipitates were 
incubated  at  30°C  either  with  or  without  vanadate  and 
then analyzed by anti-phosphotyrosine Western blotting. 
The results in Fig. 1 b show that the amount of phosphoty- 
rosine on 13-catenin was reduced by incubation in the ab- 
sence of vanadate (lane 2), relative to in the presence of 
vanadate  (lane 1).  Reprobing the blot demonstrated the 
amount of 13-catenin was unchanged (lower panel). There- 
fore, this 13-catenin immune precipitate contained tyrosine 
phosphatase activity which dephosphorylated [3-catenin in 
vitro. 
To examine  the  phosphatase  activity in  [3-catenin im- 
mune precipitates further, phosphatase  assays were con- 
ducted using an exogenous tyrosine-phosphorylated pep- 
tide substrate  (Fig.  1 c).  [3-Catenin immune  precipitates 
from PC12  6-24  cells contained significant phosphatase 
activity when compared to control immune  precipitates. 
The phosphatase activity did not dephosphorylate a serine- 
phosphorylated  peptide  (data  not  shown),  suggesting  it 
was specific for phosphotyrosine. 
The Cadherin-Catenin Complex Associates 
with LAR-related Phosphatases 
We sought to identify the tyrosine phosphatase associated 
with the cadherin-catenin complex. There are several can- 
didates that could play this role: the SH2-containing pro- 
tein  tyrosine  phosphatases  SHP-1  and  SHP-2,  both  of 
which are expressed in PC12 cells (Vambutas et al., 1995), 
are cytoplasmic phosphatases that bind tyrosine-phosphor- 
ylated  proteins.  SHP-1  is  activated  by  NGF  treatment 
(Vambutas et al., 1995); RPTPtx is  a transmembrane  ty- 
rosine phosphatase that shares weak sequence homology 
with cadherins (Tonks et al.,  1992) and appears to associ- 
ate directly with cadherins (Brady-Kalnay et al.,  1995); fi- 
nally, at least two members of the LAR subfamily of trans- 
membrane tyrosine phosphatases  are expressed in PC12 
cells, and their mRNA levels are increased in NGF-treated 
PC12 cells (Pan et al., 1993; Zhang and Longo, 1995). 
We were unable to detect association between SHP-1 or 
SHP-2 with the cadherin-catenin complex, and RPTPIx is 
not expressed in PC12 cells (Kypta, R.M., unpublished ob- 
servations; Gebbink et al., 1995). To examine the possibil- 
ity that LAR-PTPs mediate dephosphorylation of [3-cate- 
nin, we prepared an antibody (called 8-end) to a peptide 
corresponding to the common carboxyl-terminal tail of the 
LAR subfamily of PTPs. b-end immune precipitates from 
radiolabeled  PC12  6-24  cell  extracts  contained  at  least 
four specific proteins, with apparent molecular masses of 
approximately 150,  105, 95, and 80 kD  (Fig. 2 a, lane 2). 
These proteins were not present when the antiserum was 
incubated with cell extracts in the presence of the b-end 
peptide (lane 1). In other experiments, the 150- and 80-kD 
proteins could further be resolved into multiple bands, and 
the 80-kD proteins were recognized in Western blots using 
the b-end antiserum (data not shown). These results are 
consistent with previous studies using antibodies to LAR 
and  PTPb,  which  have shown  that  the  mature  forms of 
these phosphatases consist of a 150-kD extracellular frag- 
ment  (E subunit)  and  a  noncovalently associated 85-kD 
fragment  (P subunit)  containing extracellular, transmem- 
brane, and cytoplasmic sequences (Streuli et al.,  1992; Yu 
et  al.,  1992;  Pulido  et  al.,  1995a).  For convenience, the 
LAR subfamily proteins recognized by the antibody b-end 
will  be called LAR-PTPs in this paper. Interestingly, the 
two additional major radiolabeled proteins specifically im- 
mune precipitated by b-end antibodies (Fig. 2 a, lane 2) 
comigrated with [3- and ~-catenins (Fig. 2 a, lanes 4 and 6, 
respectively), suggesting  that  they might  be  LAR-PTP- 
associated catenins. 
To provide stronger evidence for association of LAR- 
PTPs and catenins, b-end immune precipitates were probed 
with  antibodies  to  components  of the  cadherin-catenin 
complex. The results demonstrated the presence of c~-cate- 
nin (Fig. 2 b, lane 2), cadherin (Fig. 3), and [3-catenin  (Fig. 
4).  Results  of an  anti--~-catenin Western  blot (Fig. 2  b) 
show that c~-catenin was detected in b-end immune precip- 
itates  prepared in the  presence of an  irrelevant control 
peptide (lane 2) but not in g-end immune precipitates pre- 
pared in the presence of the immunogen, the g-end pep- 
tide  (lane  1).  In  addition,  control  immune  precipitates 
(lanes 3 and 4) did not contain a-catenin, and the presence 
of a-catenin  in  anti--a-catenin  immune  precipitates  was 
not affected by incubation with either b-end (lane 5)  or 
control (lane 6) peptides. 
Comparison  of the  relative  amounts  of cadherin  de- 
tected in c~-catenin and b-end immune precipitates (Fig. 3 a) 
suggested that the  amount of cadherin associated with 
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the  cadherin-catenin  com- 
plex  with  LAR-related  pro- 
teins.  (a)  Immune  precipi- 
tates  from  equal  amounts 
of  [35S]methionine/cysteine- 
labeled  PC12  6-24  cell  ex- 
tracts were visualized  by au- 
toradiography: Anti-g-end in 
the presence of ~-end peptide 
(lane 1), anti-g-end (lane 2), 
anti-13-catenin in the presence 
of purified t3-catenin (lane 3), 
anti-13-catenin  (lane 4), anti-a-catenin in the presence of cognate peptide (lane 5), and anti-a-catenin (lane 6). The lines without arrows 
on the right indicate the positions of molecular mass markers (100.6 kD and 71.6 kD). The positions of proteins specifically  immune- 
precipitated by anti~5-end antibodies are indicated by the arrows on the left. The fastest migrating band corresponds to LAR-PTP P 
subunits.  The positions of a-catenin (lane 6), 13-catenin (lane 4), and the LAR-PTP P subunit (lane 2) were confirmed by transfer of ra- 
diolabeled immune precipitates  to nitrocellulose  and subsequent Western blotting.  In lane 3, immune precipitation using anti-13-catenin 
antibodies  in the presence of purified unlabeled 13-catenin blocked association of the antibody with labeled 13-catenin but not with c~-cate- 
nin, probably because a-catenin bound to the purified 13-catenin in the immune precipitate. (b) The following immune precipitates from 
equal amounts of cell extracts were probed with anti-~-catenin antibody: Anti-g-end in the presence of either g-end peptide (lane 1) or 
control peptide (lane 2), anti--control peptide in the presence of either g-end peptide (lane 3) or control peptide (lane 4), and anti--a-cate- 
nin in the presence of either ~-end peptide (lane 5) or control peptide (lane 6). The lines on the left indicate the positions of molecular 
mass markers (208 kD, 100.6 kD, and 71.6 kD). 
Figure 3.  Association of LAR-PTPs with cadherin.  (a) The fol- 
lowing immune precipitates  from equal  amounts of cell  extract 
were probed with anti-pan cadherin antibody: Control anti-pep- 
tide antibody (lane 1), anti-8-end (lane 2), anti--a-catenin (lanes 3 
and 4; lane 3 contained 20 times more immune precipitate than 
lane 4). Lane 5 contains cell extract.  The lines on the left indicate 
the positions of molecular mass markers (208 kD, 100.6 kD, and 
71.6 kD). (b) Cell extracts depleted using the following antibod- 
ies were loaded in equal amounts (except where indicated) and 
probed using anti-pan cadherin antibodies: Control anti-peptide 
antibody (lane 1), anti-g-end (lanes 4 and 5), and anti--a-catenin 
(lanes 6 and 7). Lanes 2, 3, and 8 contained 90%, 80%, and 20%, 
respectively, of the amount of extract loaded in lane 1. The lines 
on the left indicate the positions of molecular mass markers (208 
kD, 100.6 kD, and 71.6 kD). 
c~-catenin (lane 3) was about 10 times that associated with 
LAR-PTPs  (lane 2).  For comparison,  lane  4  contains  20 
times  less a-catenin  immune  precipitate  than  lane 2.  To 
determine  the  fraction  of total  cadherin  associated  with 
LAR-PTPs,  we  depleted  PC12  cell  extracts  using  either 
control, e~-catenin, or g-end antibodies,  and measured the 
amount of cadherin remaining (Fig. 3 b). The results from 
duplicate  experiments  were  quantitated  by densitometry 
and comparison with known amounts of cell extracts that 
had been incubated with control antibodies. While a-cate- 
nin antibodies depleted over 80% of cadherin (lanes 6 and 
7),  g-end antibodies  depleted  8%. Therefore,  about  10% 
of cadherin-catenin  complexes  in  PC12  cells  are  associ- 
ated with LAR-PTPs. 
Octylglucoside, but not NP-40, has been shown to selec- 
tively dissociate c~-catenin from the cadherin-catenin com- 
plex (Ozawa and Kemler, 1992). We compared the associ- 
ation  of LAR-PTPs  with  catenins  after  lysis  in  buffers 
containing either NP-40 or octylglucoside (Fig. 4). Cell ex- 
tracts prepared in NP-40 lysis buffer (lane 7) and octylglu- 
coside lysis buffer (lane 8) contained similar amounts of 
a-catenin  (Fig.  4,  upper panel,  lanes  7  and  8),  ~-catenin 
(lower panel,  lanes  7  and  8),  and  LAR-PTPs  (data  not 
shown).  As anticipated,  preparation  of PC12 cell extracts 
in octylglucoside, but not NP-40, disrupted  association  of 
a-catenin with cadherin (upper panel, lanes 3  and 4) and 
[3-catenin (lanes 5  and 6). Interestingly, the association of 
LAR-PTPs with ~-catenin was also disrupted after lysis in 
octylglucoside but not NP-40 (upper panel, lanes 1 and 2). 
Reprobing the membranes with anti-[3-catenin antibodies 
(Fig.  4,  lower panel)  indicated  that,  while  octylglucoside 
did not affect the association between  [3-catenin and cad- 
herins (lanes 3 and 4), it disrupted the association between 
13-catenin and LAR-PTPs (lanes 1  and 2).  Since octylglu- 
coside  disrupts  the  association  of LAR-PTPs with  both 
~-catenin and [3-catenin, this experiment does not demon- 
Kypta et al. Cadherin/Catenins  Associate with  LAR-related  PTPase  1523 Figure 4.  LAR-PTPs dissociate from the cadherin- 
catenin  complex in octylglucoside. Anti--a-catenin 
(upper panel) and  anti-13-catenin  (lower panel) 
Western blots of immune precipitates (lanes 1--6) or 
extracts (lanes 7 and 8) from PC12 6-24 cells tysed 
either in NP-40-containing lysis buffer (n, lanes 1, 3, 
5, and 7) or lysis buffer containing 40 mM octylgtu- 
coside (o, lanes 2, 4, 6, and 8). Immune precipitates 
from equal  amounts of cell  extract were prepared 
using anti--45-end (lanes 1 and 2), anti-pan-cadherin 
(lanes 3  and 4) and anti-13-catenin  (lanes 5 and 6) 
antibodies. The lines on the left of each panel indi- 
cate the positions of molecular mass markers (100.6 
kD  and  71.6  kD).  There  is  a  residual  signal  of 
0t-catenin  in the blot shown in the lower panel be- 
cause the blot in the upper panel was reprobed with- 
out stripping. 
strate which protein in the cadherin-catenin complex me- 
diates the interaction of this complex with LAR-PTPs. 
The Amino-terminal Domain of ~Catenin Is Required 
for Association of the Cadherin-Catenin Complex with 
LAR-PTPs 
To determine  which component of the cadherin--c.atenin 
complex  mediates  the  interaction  with  LAR-PTPs,  we 
constructed  a  number  of  myc-epitope-tagged  13-catenin 
deletion  mutants and expressed  them transiently  in COS 
cells  (Fig.  5).  The  upper  panel  of Fig.  5  is  an  anti-myc 
(9El0)  Western  blot  of  whole  cell  extracts  containing 
these constructs. We previously observed that LAR-PTPs 
associate  with  the cadherin-catenin  complex in some  fi- 
broblast cell lines, including COS cells, although to a lesser 
extent than in PC12 cells (Kypta, R.M., data not shown). 
Therefore, ~-end immune precipitates were prepared from 
COS cell extracts that contained  13-catenin deletion  mu- 
tants and then probed with antibodies  that recognize the 
myc-epitope tag (Fig. 5, lower panel).  As expected,  full- 
length, myc-epitope-tagged t3-catenin  (t3)  associated with 
both LAR-PTPs (lower panel, lane 1) and a-catenin (data 
not shown). Deletion of the amino-terminal domain (/iN, 
lane 2) but not the carboxyl-terminal domain (zaC, lane 3) 
of 13-catenin prevented association of 13-catenin with both 
LAR-PTPs (lower panel)  and  with  a-catenin  (data  not 
shown).  Interestingly,  a  13-catenin mutant  lacking the  ar- 
madillo  repeat  region  (AR)still  associated  with  LAR- 
PTPs (lower panel, lane 5). 
Since cadherins associate with the armadillo repeat  re- 
gion of 13-catenin, these results indicate that, in contrast to 
RPTPv,,  LAR-PTPs  do  not  interact  directly  with  cad- 
herins.  However,  these  experiments  do  not  address 
whether the amino-terminal domain of 13-catenin directly 
binds LAR-PTPs or if the association is mediated by a-cate- 
nin  (or  an  unknown  protein).  To  determine  the  impor- 
tance of ct-catenin to the association between  LAR-PTPs 
and  the cadherin-catenin complex,  we prepared  extracts 
from PC9 cells (Fig. 6). PC9 cells do not express et-catenin, 
but  do  express  13-catenin  and  cadherins  (Hirano  et  al., 
1992).  As expected,  anti--a-catenin  antibodies  coimmune 
precipitated 13-catenin from extracts of PC12 cells (lane 2), 
but not from extracts of PC9 cells  (lane 5).  Interestingly, 
13-catenin  was found  in ~i-end  immune  precipitates  from 
both PC12 cells (lane 3) and PC9 cells (lane 6). 
To summarize, these results indicate that LAR-PTPs as- 
sociate with the cadherin--catenin complex through an in- 
teraction  with  the  amino-terminal  domain  of  13-catenin 
and  that  13-catenin  does  not  have  to  associate  with  cad- 
herins or a-catenin to mediate this interaction. 
Figure 5.  The amino-terminal domain of 13-catenin is required for 
association  of LAR-PTPs with  the  cadherin-catenin  complex. 
Anti-myc lag (9El0) Western blots of extracts (upper  panel) and 
anti-,5-end immune precipitates (lower panel) from extracts  of 
COS cells  transfected  with  the  indicated  13-catenin expression 
constructs./3, full-length myc-tagged [3-eatenin (lane 1);/IN, resi- 
dues 174-781 {lane 2); /tC, residues 1-698 (lane 3); ANAC,  resi- 
dues 174-698 (lane 4); AR, residues 1-151 fused to residues 648- 
781 (lane 5), or cells transfected with empty vector (lane 6). The 
arrows indicate the positions of fl (lane 1), AC (lane 3), and AR 
(lane 5). The lines on the left of each panel indicate the positions 
of molecular mass markers (100.6 kD, 71.6 kD, and 43.5 kD). The 
bands running above the position of the bottom arrow are IgG 
heavy chain, which cross-reacts with the secondary antibody: 
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catenin  complex  does  not  require  a-catenin.  Anti-13-catenin 
Western blot of immune precipitates from PC12 cells (lanes 1-3) 
or PC9 cells (lanes 4-45). Antibodies used for immune precipita- 
tion were anti-[3-catenin (lanes 1 and 4), anti--~-catenin  (lanes 2 
and 5), and anti-g-end (lanes 3 and 6). The lines  on the left  of 
each  panel  indicate  the  positions  of molecular  mass  markers 
(100.6 kD and 71.6 kD). 
TrkA-dependent Tyrosine Phosphorylation 
of LAR-PTPs 
Tyrosine phosphorylation of 13-catenin might be expected 
to alter its interaction either with LAR-PTPs, cadherin, or 
other  catenins.  However,  we  have  not  observed  such 
changes after vanadate treatment of PC12 6-24 cells (data 
not  shown).  As  another  possibility,  activation  of  TrkA 
may result in changes in LAR-PTP catalytic activity, per- 
haps by tyrosine phosphorylation of the latter.  We there- 
fore examined the possibility that LAR-PTPs are tyrosine 
phosphorylated.  Results  in  Fig.  7  show  that  addition  of 
vanadate  to  NGF-treated  PC12  6-24  ceils  increased  ty- 
rosine  phosphorylation  of  the  P  subunit  of  LAR-PTPs 
(lane 4) and 13-catenin (lane 2). This phosphorylation was 
blocked  by  the  TrkA  inhibitors  K252a  and  tyrphostin 
AG879 (data not shown), suggesting that TrkA activation 
is  necessary for tyrosine  phosphorylation  of LAR-PTPs. 
We were unable to detect changes in LAR-PTP tyrosine 
phosphorylation or catalytic activity after addition of NGF 
alone  (Kypta,  R.M.,  unpublished  observations),  perhaps 
because  LAR-PTPs are  rapidly  dephosphorylated  in  the 
absence of tyrosine phosphatase inhibitors. It thus remains 
possible  that  LAR-PTP activity  is  regulated  by tyrosine 
phosphorylation, but that this was not detectable  using in 
vitro assays. 
To determine whether TrkA induces tyrosine phosphor- 
ylation of LAR-PTPs without the addition of vanadate to 
living  cells,  LAR-PTPs  were  coexpressed  with  TrkA  in 
COS cells (Fig. 7 b). COS cells were transfected with cDNAs 
expressing human LAR (lanes 1 and 2) and human RPTPb 
(lanes 3 and 4) together with plasmids containing rat TrkA 
eDNA (lanes 2  and 4) or TrkA eDNA cloned in the anti- 
sense  orientation  as  a  control  (lanes 1  and 3).  LAR and 
RPTP~ immune precipitates from transfected COS cell ex- 
tracts  were  probed  sequentially  with  antibodies  to  anti- 
phosphotyrosine  (upper  panel)  and  ~-end  antibodies 
(lower panel).  Expression of TrkA induced tyrosine phos- 
phorylation of both LAR (upper panel, lane 2) and RPTP~ 
(lane 4). Therefore, LAR-PTPs can be tyrosine-phosphor- 
Figure  7.  TrkA  induces  ty- 
rosine  phosphorylation  of 
LAR-PTPs.  (a)  Tyrosine 
phosphorylation  of  LAR- 
PTPs  in  PC12  6--24 cells. 
Western  blots  of  immune 
precipitates  from  equal 
amounts  of  cell  extracts  of 
NGF-treated  cells  that were 
either untreated (lanes 1 and 
3)  or treated  with  vanadate 
(lanes  2  and 4) before lysis, 
prepared using anti-13-catenin 
(lanes 1 and 2) or anti-g-end 
(lanes  3  and  4)  antibodies, 
were probed with anti-phos- 
photyrosine  antibodies  (up- 
per panel) or anti-g-end anti- 
bodies  (lower panel).  The 
positions of LAR-PTP P sub- 
units and 13-catenin are indi- 
cated. The lines on the left of 
each panel indicate the posi- 
tions of molecular mass markers (upper  panel: 100.6 kD and 71.6 kD; lower  panel: 208 kD, 100.6 kD, and 71.6 kD). Tyrosine-phosphory- 
lated 13-catenin is detectable in g-end immune precipitates (upper panel, lane 4). Vanadate does not alter the amount of LAR-PTPs 
(lower panel, compare lanes 3 and 4). (b) TrkA expression in COS cells induces tyrosine phosphorylation of LAR and RPTPS. Anti- 
phosphotyrosine (upper panel) and anti-g-end (lower  panel) Western blots of anti-LAR (lanes 1 and 2) or anti-RPTP~ (lanes 3 and 4) 
immune precipitates from equal amounts of cell extracts of COS cells transfected with vectors expressing LAR eDNA (lanes 1 and 2), 
RPTP8 eDNA (lanes 3 and 4), control DNA (lanes I  and 3), or TrkA eDNA (lanes 2 and 4). In each panel, the arrows mark the posi- 
tions of uncleared LAR-PTP P+E subunits (top arrows) and cleaved LAR-PTP P subunits (bottom arrows). The lines on the right of 
each panel indicate the positions of molecular mass markers (208 kD, 100.6 kD, and 71.6 kD). The additional band recognized by anti- 
g-end antibodies (lower panel, lanes 3 and 4) may be a breakdown product of RPTPS, since it was observed only in COS cells trans- 
fected with RPTP8 eDNA. 
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cadherin-catenin  complex  by  NGF.  (a) 
NGF  increases  cellular  levels  of  LAR- 
PTPs. Western blots of extracts  (lanes 1--6) 
or  g-end  immune  precipitates  (lanes  7 
and8)  from  untreated  PC12  6-24  cells 
(lanes  1, 3, 5, and  7) or PC12 6--24 cells 
treated with NGF for 16 h  (lanes 2, 4, 6, 
and 8) were probed with anti-pan cadherin 
(lanes  1  and  2),  anti-a-catenin  (lanes  3 
and 4), anti-t3-catenin (lanes 5 and 6), and 
anti-g-end (lanes  7 and 8) antibodies.  The 
lines on the right  of lanes  1~5 and on the 
left of lanes 7 and 8 indicate the positions 
of molecular mass markers (208 kD, 100.6 
kD, and 71.6 kD). These blots were devel- 
oped using a colorimetric assay.  (b) NGF 
treatment results in downregulation of the 
LAR-PTP-cadherin-catenin  complex. 
Western  blots  of  immune  precipitates 
from equal amounts of cell extracts of un- 
treated cells (lanes 1, 3, 5, and 8) or cells 
treated with  NGF for 16 h  (lanes 2, 4, 6, 
and  7) using anti-a-catenin  (lanes  1 and 
2),  anti-[?,-catenin  (lanes  3  and  4),  and 
anti-g-end  (lanes  5~)  antibodies  were 
probed  with  anti-[3-catenin  monoclonal 
antibody (lanes 1~5) or both anti-[3-cate- 
nin and anti-g-end antibodies (lanes 7 and 
8,  developed using a  colorimetric assay). 
The lines on the left of the panel indicate 
the  positions of molecular mass markers 
(100.6 kD and 71.6 kD). 
ylated  in  a  TrkA-dependent  manner  both  in  PC12  6-24 
cells and in COS cells. 
Downregulation of the LAR-PTP-Cadherin-Catenin 
Complex by NGF 
Addition of NGF to PC12 cells has been shown to increase 
the  levels  of  N-cadherin,  LAR,  and  PTP-P1  mRNAs 
(Doherty et al.,  1991; Pan et al.,  1993; Zhang and Longo, 
1995). We compared the relative amounts of components 
of the LAR-PTP-cadherin-catenin complex in PC12 6-24 
cells either untreated or treated with NGF for 16 h (Fig. 8 a). 
Relative to their levels in untreated PC12 6-24 cells (lanes 
1, 3, and 5), treatment of PC12 6-24 cells with NGF did not 
change  the  levels  of cadherin  (lanes  1  and 2),  a-catenin 
(lanes 3 and 4), or 13-catenin (lanes 5 and 6). In contrast, a 
small increase in the level of LAR-PTPs was seen after ad- 
dition of NGF to PC12 6-24 cells (lanes  7 and 8), consis- 
tent with the NGF-induced increases in mRNA levels de- 
scribed for PTP-P1 and LAR (Pan et al., 1993; Zhang and 
Longo, 1995). 
We next compared the relative amounts of LAR-PTP- 
cadherin-catenin complexes in untreated and NGF-treated 
PC12 6-24 cells (Fig. 8 b). While NGF treatment of PC12 
6-24 cells did not detectably alter the amount of 13-catenin 
associated with a-catenin (lanes 1 and 2) or with cadherin 
(data not shown), Western blotting of ~-end immune pre- 
cipitates  showed that  the amount of 13-catenin associated 
with LAR-PTPs decreased about twofold after NGF treat- 
ment (lanes 5  and 6).  This change is best observed when 
the same ~-end immune precipitates are probed with both 
anti-[3-catenin  and  ~-end  antibodies  (lanes  7  and  8). 
Therefore,  although the  levels  of LAR-PTPs increase  in 
NGF-treated  PC12  6-24  cells,  there  is  a  decrease  in  the 
relative amount of associated [3-catenin. 
To summarize the data presented in Figs. 7 and 8, LAR- 
PTPs  have  the  potential  to be  regulated  by NGF in  the 
short  term  by tyrosine  phosphorylation,  and  in  the  long 
term by increases in protein levels. In addition, LAR-PTP 
interactions  with  the  cadherin-catenin  complex  are  also 
regulated, as documented by the reduction in their associ- 
ation observed in NGF-treated cells. 
Discussion 
The results from a  number of studies have suggested that 
13-catenin tyrosine phosphorylation plays a dynamic role in 
processes such as cell aggregation (Matsuyoshi et al., 1992; 
Hamaguchi et al., 1993), cell migration (Hamaguchi et al., 
1993; Shibamoto et al., 1994), and epithelial differentiation 
(Behrens et al., 1993). Rapid regulation of these events re- 
quires  that  phosphorylation  be  tightly  controlled  by  ty- 
rosine  kinases  and  phosphatases.  Indeed,  receptor  tyro- 
sine  kinases  associate  with  ~-catenin  in  some  cell  lines 
(Hoschuetsky et al.,  1994; Ochiai et  al.,  1994),  but not in 
others  (Matsuyoshi  et  al.,  1992;  Hamaguchi  et  al.,  1993; 
Behrens et al., 1993; Shibamoto et al., 1994). We have ex- 
amined  phosphorylation/dephosphorylation  mechanisms 
of 13-catenin in PC12 cells and have found that 13-catenin is 
associated with a  tyrosine phosphatase.  This phosphatase 
is  capable  of dephosphorylating  13-catenin  itself  in  vitro. 
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in vanadate-treated PC12 6--24 cells strongly suggests that 
this association also occurs in vivo. 
The association  of the  major components of the  cad- 
herin-catenin  complex was  not  detectably  altered  after 
vanadate-induced  tyrosine phosphorylation of [3-catenin 
(data not shown), as was observed by others using v-src- 
transformed cells (Behrens et al., 1993). However, trans- 
formation of epithelial  cells  by ras,  which  increases  ty- 
rosine phosphorylation of [3-catenin, results in dissociation 
of [3-catenin and cadherin (Kinch et al.,  1995).  Therefore, 
there may be cell-type specific differences in the regula- 
tion of cadherin--catenin interactions by tyrosine phosphor- 
ylation. These might be determined by phosphorylation of 
specific tyrosine residues on [3-catenin or by phosphoryla- 
tion of other proteins. 
One possible result of increased tyrosine phosphoryla- 
tion of [3-catenin is a reduction in cadherin-dependent cell 
aggregation. We have been unable to test this possibility in 
PC12 cells, since they aggregate poorly (Kypta, R.M., un- 
published observations). Recently, expression of v-src in 
fibroblasts lacking [3-catenin was shown to shift cell adhe- 
sion mediated by a cadherin--a-catenin fusion protein from 
a strong to a weak state, suggesting that tyrosine phosphor- 
ylation of [3-catenin is not required for this shift (Takeda 
et al., 1995). Since cadherin-dependent cell aggregation in 
these fibroblasts is the same in the presence or absence of 
v-src, tyrosine phosphorylation of [3-catenin may regulate 
cadherin function of cells already in the weak state of cell 
adhesion, such as PC12 cells, during processes such as neu- 
rite outgrowth. 
Recently Brady-Kalnay et al.  (1995) reported that cad- 
herins  associate with  the  transmembrane  tyrosine phos- 
phatase RPTP~ in a mink lung epithelial cell line. While 
our  experiments do  not  address  the  possibility that  the 
cadherin--catenin complex associates with  tyrosine phos- 
phatases in addition to LAR-PTPs in PC12 cells, the activ- 
ity measured in [3-catenin immune precipitates cannot in- 
clude RPTPI~ since this protein is not expressed in PC12 
cells (Kypta, R.M., unpublished observations; Gebbink et al., 
1995). The RPTP~-related protein, RPTPK (Jiang et al., 
t993),  is  expressed  at  low  levels  in  PC12  cells  (Kypta, 
R.M.,  unpublished  observations).  Therefore, it  remains 
possible that the cadherin--catenin complex in PC12 cells 
also associates with RPTPK. 
There are a number of further differences between the 
cadherin-catenin complexes that associate with LAR-PTPs 
and RPTPI~. RPTPIx localizes to cell junctions. In contrast 
LAR-PTPs are not concentrated in cell junctions of PC12 
cells (data not shown) or MCF-7 cells (Serra-Pages et al., 
1995);  and,  while  RPTPp.  associates  directly with  cad- 
herins, the association between LAR-PTPs and the cad- 
herin-catenin complex is mediated by the amino-terminal 
domain of 13-catenin. 
The importance of the amino-terminal domain of 13-cate- 
nin for the  association  of LAR-PTPs with  the  cadherin- 
catenin complex is intriguing. While several proteins interact 
with the armadillo repeat region of [3-catenin (Kirkpatrick 
and Peifer, 1995), only e~-catenin has been shown to associ- 
ate with the amino-terminal domain of 13-catenin, and the 
binding site for a-catenin overlaps with the beginning of 
the  armadillo repeat region (Aberle et al.,  1996). Onco- 
genic forms of 13-catenin deleted in the amino-terminal do- 
main have been found (Oyama et al., 1994; Kawanishi et al., 
1995; Whitehead et al., 1995). The inability of one of these 
mutants to bind et-catenin results in reduced cell adhesion, 
which can be rescued by expression of full-length 13-cate- 
nin  (Kawanishi et al.,  1995).  It has  been suggested that 
such mutations in 13-catenin  may be involved in the  en- 
hancement of tumor invasion in human cancers (Oyama et 
al., 1994). Since these mutant forms of [3-catenin probably 
no longer associate with LAR-PTPs, it is also possible that 
disruption of the cadherin-catenin-LAR-PTP complex plays 
a role in cell transformation. Consistent with this possibil- 
ity, human LAR  (Streuli et al., 1992) and murine RPTP8 
(Mizuno et al.,  1993)  map to chromosomal regions that 
contain candidate tumor suppressor genes. 
The high  sequence  homology among  LAR-PTPs sug- 
gests that all three members associate with the cadherin- 
catenin complex. Indeed, LAR-PTPs are known to inter- 
act with a common cytoplasmic protein, LIP.1 (Pulido et al., 
1995b). To date, we have been unable to demonstrate a di- 
rect association between the cytoplasmic domain of the rat 
LAR-PTP PTP-P1 (Pan et al., 1993) and [3-catenin using gel 
overlay assays  (Kypta, R.M.,  unpublished  observations), 
so the interaction may be mediated by another protein. 
Alternatively, posttranslational modifications of 13-catenin 
or a particular isoform of PTP-P1 may be required for as- 
sociation. 
The effects of vanadate on tyrosine phosphorylation of 
LAR-PTPs in PC12 6-24 cells suggest that LAR-PTPs are 
rapidly phosphorylated and dephosphorylated in vivo. Ex- 
pression of TrkA induced tyrosine phosphorylation of LAR 
and RPTP~ in COS cells without the addition of vanadate 
before cell lysis. Interestingly, tyrosine phosphorylation of 
LAR and RPTP8 in COS cells was on their full-length, un- 
cleaved forms, rather than the cleaved P subunits of LAR- 
PTPs that were phosphorylated in vanadate-treated PC12 
6-24  ceils.  This  may  reflect  the  ratios  of uncleaved  to 
cleaved forms of LAR-PTPs in COS and PC12 cells.  An 
intriguing possibility is that cleavage of LAR-PTPs leads 
to their activation, with PC12 cells containing a higher pro- 
portion of cleaved, activated LAR-PTPs, whose phosphor- 
ylation is only detectable using vanadate. 
Assessment  of the  effects of tyrosine phosphorylation 
on LAR-PTP activity is hampered by the fact that stable 
phosphorylation requires the presence of vanadate, which 
inhibits  LAR-PTPs.  An  understanding  of  the  conse- 
quences of this phosphorylation on LAR-PTP activity will 
require  the  identification  and  mutation  of  the  TrkA- 
induced tyrosine phosphorylation sites. There is precedent 
for regulation of PTPs by tyrosine phosphorylation:  the 
nonreceptor phosphatase,  PTP1C,  is  phosphorylated on 
tyrosine in response to insulin receptor activation, and this 
correlates with  an  increase in its  activity (Uchida  et al., 
1994); RPTPa is phosphorylated constitutively on tyrosine 
(den Hertog et al.,  1994; Suet al.,  1994), and in vitro ex- 
periments suggest that tyrosine phosphorylation reduces 
the activity of this phosphatase (den Hertog et al., 1994). 
Therefore, TrkA-induced phosphorylation of LAR-PTPs 
provides a potential mechanism for regulating their activi- 
ties. 
Addition of NGF to PC12 6-24 cells reduces the associa- 
tion between LAR-PTPs and the cadherin-catenin corn- 
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association. Consistent with this possibility is the observa- 
tion that tyrosine phosphatase  activity in  13-catenin im- 
mune precipitates from parental PC12 cells, which express 
far less TrkA than PC12 6--24 cells, is higher than that in 
PC12 6-24 cells (Kypta, R.M., unpublished observations). 
It is unclear whether the reduced association seen after 
NGF treatment reflects a stoichiometric change in binding 
or a weakened association that leads to disruption of the 
complex during cell lysis and immune precipitation. An al- 
ternative explanation for the reduced association in NGF- 
treated cells is that the cadherin-catenin complex associates 
with a modified form of LAR-PTPs, such as one containing 
a differentially spliced exon. This is an exciting possibility, 
since isoforms of LAR, RPTP~,  and RPTP~r  do contain 
additional cytoplasmic residues  encoded  by such  exons 
(Pulido  et  al.,  1995b),  which,  at  least in  LAR, become 
downregulated after NGF treatment of PC12 cells (Zhang 
and Longo, 1995). 
Recently DLAR, a Drosophila LAR-PTP expressed in 
developing neurons, was shown to play a key role during 
motor neuron growth cone guidance (Krueger et al., 1996). 
Although all neurons  express  DLAR, only a  subset  of 
neurons make axon-pathfinding errors in Dlar mutant em- 
bryos. While this observation may reflect the restricted lo- 
calization of the putative ligand for DLAR, it may also de- 
lineate  specific  cadherin-dependent  guidance  pathways. 
N-cadherin--dependent  neurite  outgrowth is  affected by 
inhibition of tyrosine phosphorylation (Bixby and Jhab- 
vala, 1992; Williams et al., 1994). In addition, neurite out- 
growth of PC12 cells growing on purified N-cadherin re- 
quires NGF and is blocked both by TrkA inhibitors and 
vanadate  (Kypta, R.M.,  unpublished  observations),  sug- 
gesting that it requires tyrosine kinase and phosphatase 
activities. Our immunocytochemical experiments (Kypta, 
R.M., unpublished observations) indicate that LAR-PTPs 
and cadherins/catenins partially colocalize in neurites, fur- 
ther  suggesting  a  role  for  the  complex  in  neurite  out- 
growth. Indeed, the chicken LAR-PTP, CRYP-a, which is 
expressed within both  the  lamellipodia and filopodia of 
neuronal  growth  cones,  has  been  proposed  to  regulate 
growth cone migration (Stoker et al., 1995). 
The LAR-PTP-cadherin-catenin complex is most abun- 
dant in PC12 cells but is also present in fibroblasts, sug- 
gesting that it may also have a  more general function. 
We propose that cycles of 13-catenin tyrosine phosphoryla- 
tion and dephosphorylation provide a mechanism rapidly 
to regulate cell-cell interactions, which may be required 
for cadherin-dependent functions that include neurite out- 
growth (Bixby et al., 1988; Matsunaga et al., 1988; Toma- 
selli et al., 1988; Bixby and Jhabvala, 1990) and cell motility 
(Hamaguchi et al., 1993; Nagafuchi et al., 1994; Shibamoto 
et al.,  1994).  An alternative function for the LAR-PTP- 
cadherin-catenin complex might be to regulate the signal- 
ing function of 13-catenin. For example, LAR-PTPs may be 
involved in transducing Wnt signals. 
There are three, not mutually exclusive ways in which such 
mechanisms might operate. First, catenins could serve as a 
link between LAR-PTPs and the actin-based cytoskeleton. 
This would provide a mechanism to stabilize potential ad- 
hesive interactions mediated by the extracellular domains 
of  LAR-PTPs.  Second,  coclustering  of  cadherins  and 
LAR-PTPs may result in  activation of LAR-PTPs. This 
would maintain 13-catenin in the dephosphorylated state, 
which may be a prerequisite for cadherin-dependent cell 
adhesion (Matsuyoshi et  al.,  1992; Behrens et  al.,  1993; 
Hamaguchi et al.,  1993).  Third, association of 13-catenin 
with LAR-PTPs could allow a  rapid reversal  of growth 
factor-induced tyrosine phosphorylation of 13-catenin. Ex- 
tracellular signals transduced by binding of putative ligands 
to LAR-PTPs would then provide additional pathways to 
modulate cadherin function. 
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